Triparna Sen/X
May 8, 2025, 17:23
Triparna Sen presented new research on immune evasion in Small Cell Lung Cancer at AAI IMMUNOLOGY 2025
Triparna Sen, Director of the Lung Cancer PDX Platform at the Icahn School of Medicine at Mount Sinai, shared a post on X:
“Thrilled to be at The American Association of Immunologists (AAI) IMMUNOLOGY 2025 – where brilliant basic and translational immunology is on full display. This is an amazing meeting to learn and collaborate with colleagues who are pushing the boundaries of immunology discoveries.
I am honored to speak on the novel regulators of antigen presentation to overcome immune evasion in Small Cell Lung Cancer (SCLC), highlighting how improving immune visibility in this historically ‘cold’ cancer may unlock new therapeutic strategies.
A bonus to be selected as a meeting ambassador and career development round table leader-combining science and mentorship, which is truly my happy place.”
More posts featuring Triparna Sen on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 9, 2025, 09:39
May 9, 2025, 09:37
May 9, 2025, 09:22
May 9, 2025, 09:15
May 9, 2025, 08:15
May 9, 2025, 07:41